Lv1
65 积分 2021-03-03 加入
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
5天前
已完结
Epigenomic heterogeneity as a source of tumour evolution
5天前
已完结
Navigating the Evolving Landscape of EGFR-Mutated NSCLC
5天前
已完结
Evaluation of the sensitivity and specificity of sigmoidoscopy in comparison to colonoscopy regarding the detection of intestinal inflammatory activity in the follow-up of patients with ulcerative colitis
17天前
已关闭
Clinical efficacy of Guishao Shengxue decoction in the treatment of pediatric immune thrombocytopenia: A randomized controlled trial
30天前
已完结
EMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets
1个月前
已完结
Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitor
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis-the TACTIC-UC study
1个月前
已完结
Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: An observational study
1个月前
已关闭
皖公网安备34019202002308
